Codexis (CDXS) Stock Surges on GlaxoSmithKline Licensing Deal
July 15, 2014 at 09:57 AM EDT
Shares of Codexis Inc. (CDXS) were up +1.34 or +95.04 percent to $2.75 per share in pre-market trading early this morning, after the company announced late yesterday a platform technology agreement with GlaxoSmithKline (GSK). Codexis Inc. stock closed at $1.41, down -0.04 or -2.76 percent in Monday’s regular trading session. Redwood City, California based Codexis Read the full article... Read the rest of Codexis (CDXS) Stock Surges on GlaxoSmithKline Licensing Deal at InvestorGuide.com .
